Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses

about

The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

P2860

Q38815425-CE0BA345-4949-4F48-8CAA-06667DE60EC3

P2860

Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses

Item

http://www.wikidata.org/entity/Q35637980

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@ast

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@en

type

Item

label

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@ast

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@en

prefLabel

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@ast

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@en

P1476

Cardiac β-Adrenoceptor Express ...... as Type-2 Diabetes Progresses

@en

P2093

James M Haley

http://www.w3.org/2001/XMLSchema#string

James T Thackeray

http://www.w3.org/2001/XMLSchema#string

Jean N DaSilva

http://www.w3.org/2001/XMLSchema#string

Stephanie L Thorn

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.

Leptin and hyperleptinemia - from friend to foe for cardiovascular function.

Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance.

Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.

Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats

Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study

Adenylyl cyclase subtype-specific compartmentalization: differential regulation of L-type Ca2+ current in ventricular myocytes

Treatment of Zucker diabetic fatty rats with AVE7688 improves vascular and neural dysfunction

P304

e0127581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0127581

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277939838

http://www.w3.org/2001/XMLSchema#string

P698

25996498

http://www.w3.org/2001/XMLSchema#string

P932

4440709

http://www.w3.org/2001/XMLSchema#string

Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses

about

P2860

P2860

Cardiac β-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932